Posts Tagged ‘amd’
Could weight loss injections be affecting your eyes?
New Research Links GLP-1 Medications to Macular Degeneration Risk If you are taking popular weight loss or diabetes medications such as Ozempic, Wegovy or Mounjaro, it may be time to look more closely—at your eye health. A new large-scale study from the University of Toronto, published in JAMA Ophthalmology and featured in Optometry Today (June 2025),…
Read MoreNon-Invasive Dry AMD Therapy available in Kingston upon Thames, London
A breakthrough in photobiomodulation therapy for eye health — at John Rose Eye Care If you or a loved one has been diagnosed with dry Age-related Macular Degeneration (AMD) — or you are at risk and looking for proactive, private eye care in Richmond, Barnes, Surbiton, London or across Surrey — we invite you…
Read MoreValeda LDS – the first and ONLY FDA-authorised treatment for dry AMD to improve vision!
A New Era in Macular Degeneration Care – Safe, Effective and Non-Invasive 🔹 Key Highlights ✅ Rigorous Clinical Trials: LightSite II and LightSite III confirmed effectiveness. ✅ FDA-Approved (November 2024): The first and only treatment using photobiomodulation (PBM) for AMD to receive FDA approval. FDA Approval Announcement ✅Proven Track Record: Over 750,000 treatments performed worldwide…
Read MoreDiscover the Latest in Dry AMD Treatment with John Rose Optometrist
Join optometrist John Rose in conversation with journalist Angela Young as they discuss the FDA-approved Valeda Light Delivery System (LDS) treatment for Dry Age-Related Macular Degeneration (AMD). Hear directly from John and Alita, one of our AMD patients, about how this innovative therapy works and their personal experience with Valeda. 🎧✨ Listen to the…
Read MoreThe Valeda LDS treatment for dry AMD is now FDA approved
LumiThera has received U.S. FDA authorisation to market its Valeda® Light Delivery System, the first FDA-approved treatment for vision loss due to dry age-related macular degeneration (AMD). The non-invasive photobiomodulation (PBM) device demonstrated improved visual acuity and safety over 24 months in the pivotal LIGHTSITE III trial, with results showing that Valeda slowed disease progression…
Read MorePhotobiomodulation at John Rose Eye Care
PHOTOBIOMODULATION In 2017 we took the bold step by installing the NoviThor Whole Body Light Pod, a popular device that has revolutionized how we approach whole-body wellness. The NoviThor delivers red and near-infrared light therapy, not just for eye health but for enhancing overall physical well-being. From alleviating chronic pain to boosting energy levels, this…
Read MoreThe MP-eye Test: A New Era in Eye Health
The MP-eye Test: A New Era in Eye Health – how sunsafe are are your eyes ? At John Rose Eye Care in Kingston Upon Thames we have been offering the MP-eye test for the past year and a half as part of our comprehensive eye health examination to our clients in London, Richmond,…
Read MoreEnhancing AMD Care with AI – Q & A with John Rose Optometrist, Kingston
AMD eye diagnostics and AI At John Rose Eye Care in Kingston upon Thames we are committed to leading the way in age-related macular degeneration (AMD) care, by being the first Optometric Practice in the UK to adopt the RetinSight AI software. This innovative technology is not just about leveraging AI; it’s about significantly enhancing…
Read MoreValeda LDS, the treatment for patients suffering from Dry Age-Related Macular Degeneration
Managing Dry Macular Degeneration (AMD) Age-Related Macular Degeneration is a gradual loss of vision that progresses with age. It normally affects central vision, particularly contrast sensitivity, dark adaptation, colour vision and depth perception – changes that influence performance and experience of day-to-day tasks and hobbies such as reading, driving, watching TV, painting etc. Early stages…
Read More